Literature DB >> 23257829

VEGF isoforms.

Martine Perrot-Applanat.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23257829      PMCID: PMC3547898          DOI: 10.4161/cam.23256

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


× No keyword cloud information.
  7 in total

Review 1.  VEGF levels and the angiogenic potential of the microenvironment can affect surgical strategy for colorectal liver metastasis.

Authors:  Clarisse Eveno; Marc Pocard
Journal:  Cell Adh Migr       Date:  2012-11-01       Impact factor: 3.405

Review 2.  Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion.

Authors:  Martine Perrot-Applanat; Melanie Di Benedetto
Journal:  Cell Adh Migr       Date:  2012-11-01       Impact factor: 3.405

Review 3.  The role of VEGF 165b in pathophysiology.

Authors:  Maria Peiris-Pagès
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

Review 4.  VEGF-initiated angiogenesis and the uPA/uPAR system.

Authors:  Johannes M Breuss; Pavel Uhrin
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

Review 5.  Enhancing integrin function by VEGF/neuropilin signaling: implications for tumor biology.

Authors:  Hira Lal Goel; Arthur M Mercurio
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

Review 6.  Emerging roles for semaphorins and VEGFs in synaptogenesis and synaptic plasticity.

Authors:  Miguel Tillo; Christiana Ruhrberg; Francesca Mackenzie
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

Review 7.  The role of extracellular matrix in vascular branching morphogenesis.

Authors:  Amel Mettouchi
Journal:  Cell Adh Migr       Date:  2012-11-01       Impact factor: 3.405

  7 in total
  3 in total

Review 1.  State of the art in anti-cancer mAbs.

Authors:  S M Chiavenna; J P Jaworski; A Vendrell
Journal:  J Biomed Sci       Date:  2017-02-20       Impact factor: 8.410

2.  Protein-Protein Interaction Inhibitor of SRPKs Alters the Splicing Isoforms of VEGF and Inhibits Angiogenesis.

Authors:  Qingyun Li; Chuyue Zeng; Haizhen Liu; Kristen Wing Yu Yung; Chun Chen; Qiuling Xie; Yu Zhang; Stephanie Winn Chee Wan; Bertha Sze Wing Mak; Jiang Xia; Sheng Xiong; Jacky Chi Ki Ngo
Journal:  iScience       Date:  2021-04-20

Review 3.  Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets.

Authors:  Carlos Cuesta-Mateos; Ana Alcaraz-Serna; Beatriz Somovilla-Crespo; Cecilia Muñoz-Calleja
Journal:  Front Immunol       Date:  2018-01-17       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.